IT contractor leaves NHS programme on electronic patient records

Por Cross, Mike
Publicado em 2008

Frequent Loss of the Active Site during Variant Surface Glycoprotein Expression Site Switching In Vitro in Trypanosoma brucei

Por Cross, Mike, Taylor, Martin C., Borst, Piet
Publicado em 1998

Biosynthesis and Function of the Modified DNA Base β-d-Glucosyl-Hydroxymethyluracil in Trypanosoma brucei

Por van Leeuwen, Fred, Kieft, Rudo, Cross, Mike, Borst, Piet
Publicado em 1998

Systemic Venous Thrombosis after Recombinant Factor VIIa in the Control of Bleeding after Cardiac Surgery

Por Mahmoud, Amr, Al-Ruzzeh, Sharif, McKeague, Helena, Cross, Mike
Publicado em 2007

Expression of the human DNA glycosylase hSMUG1 in Trypanosoma brucei causes DNA damage and interferes with J biosynthesis

Por Ulbert, Sebastian, Cross, Mike, Boorstein, Robert J., Teebor, George W., Borst, Piet
Publicado em 2002

Innovative organotypic in vitro models for safety assessment: aligning with regulatory requirements and understanding models of the heart, skin, and liver as paradigms

Por Pridgeon, Chris S., Schlott, Constanze, Wong, Min Wei, Heringa, Minne B., Heckel, Tobias, Leedale, Joe, Launay, Laurence, Gryshkova, Vitalina, Przyborski, Stefan, Bearon, Rachel N., Wilkinson, Emma L., Ansari, Tahera, Greenman, John, Hendriks, Delilah F. G., Gibbs, Sue, Sidaway, James, Sison-Young, Rowena L., Walker, Paul, Cross, Mike J., Park, B. Kevin, Goldring, Chris E. P.
Publicado no Arch Toxicol (2018)